Drug-associated renal dysfunction and injury

Renal dysfunction and injury secondary to medications are common, and can present as subtle injury and/or overt renal failure. Some drugs perturb renal perfusion and induce loss of filtration capacity. Others directly injure vascular, tubular, glomerular and interstitial cells, such that specific loss of renal function leads to clinical findings, including microangiopathy, Fanconi syndrome, acute tubular necrosis, acute interstitial nephritis, nephrotic syndrome, obstruction, nephrogenic diabetes insipidus, electrolyte abnormalities and chronic renal failure. Understanding the mechanisms involved, and recognizing the clinical presentations of renal dysfunction arising from use of commonly prescribed medications, are important if injury is to be detected early and prevented. This article reviews the clinical features and basic processes underlying renal injury related to the use of common drugs.

[1]  J. Rickman,et al.  Guilt and dynamics of psychological disorder. , 1948, Lancet.

[2]  I. Estrin,et al.  ANALGESIC ABUSE AND THE KIDNEY--A COMMENTARY. , 1964, JAMA.

[3]  E. Huskisson,et al.  Azotaemia Aggravated by Tetracycline , 1970, British medical journal.

[4]  H. Cutting Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy. , 1971, The American journal of medicine.

[5]  J. Block,et al.  Antidiuretic response to cyclophosphamide in man. , 1973, The Journal of pharmacology and experimental therapeutics.

[6]  G. Eknoyan Toxic nephropathies. , 1973, Texas medicine.

[7]  B. Clayton,et al.  A VARIANT OF PHENYLKETONURIA , 1975, The Lancet.

[8]  B. Iversen,et al.  RETROPERITONEAL FIBROSIS DURING TREATMENT WITH METHYLDOPA , 1975, The Lancet.

[9]  C. Ponticelli,et al.  Late recovery of renal function in a woman with the hemolytic uremic syndrome. , 1977, Clinical nephrology.

[10]  F. Gloor,et al.  Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe. , 1978, Kidney international.

[11]  R. Nanra,et al.  Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia. , 1978, Kidney international.

[12]  R. Patel,et al.  Symptomatic hypomagnesemia associated with gentamicin therapy. , 1979, Nephron.

[13]  G. Kaloyanides,et al.  Aminoglycoside nephrotoxicity. , 1980, Kidney international.

[14]  N. Lichtenstein,et al.  Low fractional excretion of sodium with contrast media-induced acute renal failure. , 1980, Archives of internal medicine.

[15]  D. Hauglustaine,et al.  OESTROGEN CONTAINING ORAL CONTRACEPTIVES, DECREASED PROSTACYCLIN PRODUCTION, AND HAEMOLYTIC URAEMIC SYNDROME , 1981, The Lancet.

[16]  S. Johansson,et al.  Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy. , 1981, Kidney international.

[17]  A. Magil Drug-induced acute interstitial nephritis with granulomas. , 1983, Human pathology.

[18]  D M Clive,et al.  Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.

[19]  M. Rudnick,et al.  Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. , 1984, Annals of internal medicine.

[20]  A. Murgo,et al.  Renal failure and hemolytic anemia associated with mitomycin C. A case report , 1985, Cancer.

[21]  B D Kahan,et al.  De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. , 1985, Surgery.

[22]  P. H. Bach,et al.  Relevance of animal models to analgesic-associated renal papillary necrosis in humans , 1985 .

[23]  L. Giroux,et al.  Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  J. Stewart,et al.  Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer. , 1986, Kidney international.

[25]  D. Kleinknecht,et al.  Drug-associated acute renal failure. A prospective collaborative study of 81 biopsied patients. , 1987, Advances in experimental medicine and biology.

[26]  M. Fine,et al.  Cholesterol Crystal Embolization: A Review of 221 Cases in the English Literature , 1987, Angiology.

[27]  G. Deferrari,et al.  Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis. , 1989, Nephron.

[28]  G. Porter Contrast-associated nephropathy. , 1989, The American journal of cardiology.

[29]  V. V. Waters Hydralazine, hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report. , 1989, The Journal of urology.

[30]  G. Remuzzi,et al.  Thrombotic thrombocytopenic purpura and related disorders. , 1990, Hematology/oncology clinics of North America.

[31]  W. Kupin,et al.  Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients. , 1991, Transplantation proceedings.

[32]  P. Vereerstraeten,et al.  Induction of thromboses within renal grafts by high-dose prophylactic OKT3 , 1992, The Lancet.

[33]  J. Berns,et al.  Inherited hemolytic uremic syndrome in adults. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  J. Bernheim,et al.  Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  T V Perneger,et al.  Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. , 1994, The New England journal of medicine.

[36]  D. Kleinknecht Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. , 1995, Seminars in nephrology.

[37]  F. Keller,et al.  Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  W. Bennett,et al.  Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. , 1996, Kidney international.

[39]  D. Fliser Loop diuretics and thiazides--the case for their combination in chronic renal failure. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  E. Burdmann,et al.  Anuric acute renal failure caused by dextran 40 administration. , 1997, Renal failure.

[41]  J. Bosmans,et al.  Antibiotic and immunosuppression-related renal failure , 1997 .

[42]  A. Teufel,et al.  Reinstitution of gold after gold induced proteinuria. , 1997, The Journal of rheumatology.

[43]  Use of diuretics in chronic renal failure. , 1997, Kidney international. Supplement.

[44]  J. Diamond,et al.  Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations. , 1997, Journal of the American Society of Nephrology : JASN.

[45]  Mannitol-induced acute renal failure. , 1997, Journal of the American Society of Nephrology : JASN.

[46]  C. Katlama,et al.  Indinavir crystal deposits associated with tubulointerstitial nephropathy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[47]  C. Wilcox,et al.  Metabolic and adverse effects of diuretics. , 1999, Seminars in nephrology.

[48]  P. Baylor,et al.  Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  T. Kameda,et al.  Etidronate (EHDP) Inhibits Osteoclastic-Bone Resorption, Promotes Apoptosis and Disrupts Actin Rings in Isolate-Mature Osteoclasts , 1999, Calcified Tissue International.

[50]  L. Truong,et al.  FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. , 1999, Transplantation.

[51]  H. Hataya,et al.  Renal atrophy associated with long-term treatment with indinavir. , 1999, The New England journal of medicine.

[52]  T. Cihlar,et al.  Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. , 2000, Journal of the American Society of Nephrology : JASN.

[53]  V. D’Agati,et al.  Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. , 2000, Journal of the American Society of Nephrology : JASN.

[54]  M. Little,et al.  Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[55]  S. Chinnakotla,et al.  Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient. , 2000, Transplantation.

[56]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[57]  N. Ordóñez,et al.  Macrophagelike Vacuolated Renal Tubular Cells in the Urine of a Male with Osmotic Nephrosis Associated with Intravenous Immunoglobulin Therapy , 2000, Acta Cytologica.

[58]  D. Ellison Diuretic Therapy and Resistance in Congestive Heart Failure , 2002, Cardiology.

[59]  P. Kintzel Anticancer Drug—Induced Kidney Disorders , 2001, Drug safety.

[60]  J. Rossert Drug-induced acute interstitial nephritis. , 2001, Kidney international.

[61]  G. Remuzzi,et al.  Drug-Induced Thrombotic Microangiopathy , 2001, Drug safety.

[62]  P. Fine,et al.  Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. , 2001, Journal of the American Society of Nephrology : JASN.

[63]  Pathophysiology of Cyclosporine-Induced Nephrotoxicity in Humans: A Role for Nitric Oxide? , 2001, Kidney and Blood Pressure Research.

[64]  A. Serra,et al.  Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. , 2001, The American journal of medicine.

[65]  J. George,et al.  Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome , 2001, Current opinion in hematology.

[66]  D. Glotz,et al.  Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. , 2001, The American journal of medicine.

[67]  W. Bennett,et al.  Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies , 2001, Current opinion in critical care.

[68]  M. Joerger,et al.  Gemcitabine-associated hemolytic-uremic syndrome. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[69]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[70]  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002 .

[71]  Severe electrolyte disturbances and renal failure in elderly patients with combined diuretic therapy including xipamid. , 2002, Wiener klinische Wochenschrift.

[72]  H. Skelton,et al.  Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors , 2002, The British journal of dermatology.

[73]  P. Fine,et al.  Toxic acute tubular necrosis following treatment with zoledronate (Zometa). , 2003, Kidney international.

[74]  Wu-chang Yang,et al.  Tacrolimus-associated hemolytic uremic syndrome: a case analysis. , 2003, Journal of nephrology.

[75]  G. Marenzi,et al.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.

[76]  R. Quinet,et al.  Celecoxib-related renal papillary necrosis. , 2003, Archives of internal medicine.

[77]  F. S. Pereles,et al.  Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. , 2003, Journal of vascular surgery.

[78]  P. O'kelly,et al.  Acute interstitial nephritis: clinical features and response to corticosteroid therapy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[79]  J. Bonventre,et al.  Biologic markers for the early detection of acute kidney injury , 2004, Current opinion in critical care.

[80]  R. Klein,et al.  The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[81]  M. Daudon,et al.  Drug-induced renal calculi: epidemiology, prevention and management. , 2004, Drugs.

[82]  S. Tobe,et al.  Acute Interstitial Nephritis Due to Pantoprazole , 2004, The Annals of pharmacotherapy.

[83]  J. Chapman,et al.  ORAL CYCLOSPORINE BUT NOT TACROLIMUS REDUCES RENAL TRANSPLANT BLOOD FLOW , 2004, Transplantation.

[84]  Y. Shoenfeld,et al.  Intravenous immunoglobulin and the kidney--a two-edged sword. , 2004, Seminars in arthritis and rheumatism.

[85]  J. Pochet,et al.  Telithromycin-induced acute interstitial nephritis: a first case report. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[86]  K. Bhojani,et al.  NSAIDs and kidney. , 2004, The Journal of the Association of Physicians of India.

[87]  Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. , 2004, The New England journal of medicine.

[88]  Quiz page. Tubular epithelial injury consistent with osmotic nephrosis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[89]  A. Cunningham,et al.  Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy: A Randomized Controlled Trial , 2004 .

[90]  J. Cruz,et al.  Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. , 2004, Journal of neurosurgery.

[91]  M. Takano,et al.  Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. , 2004, Drug metabolism and pharmacokinetics.

[92]  Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. , 2004, The New England journal of medicine.

[93]  D. Mevorach,et al.  Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature. , 2004, Arthritis and rheumatism.

[94]  J. Buturović,et al.  Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy. , 2005, Transplantation proceedings.

[95]  New pharmacological protocols to prevent or reduce contrast media nephropathy. , 2005, Minerva cardioangiologica.

[96]  J. Frøkiaer,et al.  Altered expression of selected genes in kidney of rats with lithium-induced NDI. , 2005, American journal of physiology. Renal physiology.

[97]  T. Uehara,et al.  Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats , 2005, Archives of Toxicology.

[98]  C. Bennett,et al.  Drug-Induced Thrombotic Microangiopathy , 2005, Seminars in thrombosis and hemostasis.

[99]  Hassane Izzedine,et al.  Antiviral drug-induced nephrotoxicity. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[100]  John Anderson,et al.  Cholesterol Emboli-induced Renal Failure and Gastric Ulcer After Thrombolytic Therapy , 2005, Southern medical journal.

[101]  L. Damstrup,et al.  Retroperitoneal fibrosis after long-term daily use of ergotamine , 2005, International Urology and Nephrology.

[102]  W. Henrich Nephrotoxicity of several newer agents. , 2005, Kidney international. Supplement.

[103]  N. Lameire The pathophysiology of acute renal failure. , 2005, Critical care clinics.

[104]  M. Razzaque,et al.  Cisplatin-associated nephrotoxicity and pathological events. , 2005, Contributions to nephrology.

[105]  John R Perfect,et al.  Liposomal amphotericin B: clinical experience and perspectives , 2005, Expert review of anti-infective therapy.